2-[[[4-(4-氟苯氧基)苯基]磺?；鵠氨基] -N-羥基-2-甲基丙酰胺
|
|
|
- CAS號(hào):
- 210755-45-6
- 英文名:
- CP 471,474
- 英文別名:
- CP 471,474;PF-1626077;2-(4-(4-Fluorophenoxy)phenylsulfonamido)-N-hydroxy-2-methylpropanamide;2-[[[4-(4-Fluorophenoxy)phenyl]sulfonyl]amino]-N-hydroxy-2-methylpropanamide;Propanamide, 2-[[[4-(4-fluorophenoxy)phenyl]sulfonyl]amino]-N-hydroxy-2-methyl-
- 中文名:
- 2-[[[4-(4-氟苯氧基)苯基]磺?；鵠氨基] -N-羥基-2-甲基丙酰胺
- 中文別名:
- 化合物 T22685;化合物 CP-471474;2-[[[4-(4-氟苯氧基)苯基]磺?；鵠氨基] -N-羥基-2-甲基丙酰胺
- CBNumber:
- CB61389258
- 分子式:
- C16H17FN2O5S
- 分子量:
- 368.38
- MOL File:
- 210755-45-6.mol
|
|
|
2-[[[4-(4-氟苯氧基)苯基]磺?；鵠氨基] -N-羥基-2-甲基丙酰胺化學(xué)性質(zhì)
-
熔點(diǎn):
-
135-137°C (dec.)
-
|
-
密度:
-
1.375±0.06 g/cm3(Predicted)
-
|
-
儲(chǔ)存條件:
-
room temp
-
|
-
溶解度:
-
DMSO: ≥20mg/mL
-
|
-
酸度系數(shù)(pKa):
-
9.33±0.50(Predicted)
-
|
-
形態(tài):
-
powder
-
|
-
顏色:
-
white to off-white
-
|
2-[[[4-(4-氟苯氧基)苯基]磺酰基]氨基] -N-羥基-2-甲基丙酰胺性質(zhì)、用途與生產(chǎn)工藝
CP-471474 是一個(gè)口服有效的、廣泛的 MMP 抑制劑，IC50 值分別為1170 nM (MMP-1)、0.7 nM (MMP-2)、16 nM (MMP-3)、13 nM (MMP-9) 和 0.9 nM (MMP-13)。
|
MMP-2
0.7 nM (IC
50
)
|
MMP-13
0.9 nM (IC
50
)
|
MMP-9
13 nM (IC
50
)
|
MMP-3
16 nM (IC
50
)
|
MMP-1
1170 nM (IC
50
)
|
CP-471474 plasma levels following subcutaneous injection are 2,020 ng/mL (1 h postdose) to 160 ng/mL (6 h postdose).
CP-471,474 significantly reduces both the extent and severity of inflammation at 2 months. At 4 months, a spontaneous reduction of the inflammatory response is observed in both treated and untreated animals, and consequently no difference is observed between both.
CP-471474 significantly decreases the destructive lesions mainly at 2 months and also at 4 months.
|
Animal Model:
|
Guinea pigs weighing 400 to 450 g (COPD).
|
|
Dosage:
|
20 mg/kg (also supplemented daily by the diet (200 mg/200 g powdered chow)).
|
|
Administration:
|
Subcutaneously (in 20% ethanol/80% polyethylene glycol), once a day during the entire course.
|
|
Result:
|
Lungs derived from smoking animals treated with the compound demonstrated a statistically significant reduction in the destructive lesions.
Showed an increase of both pro–MMP-9 and its active form (lanes 5 to 8) as compared with control animals.
|
2-[[[4-(4-氟苯氧基)苯基]磺酰基]氨基] -N-羥基-2-甲基丙酰胺
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
2-[[[4-(4-氟苯氧基)苯基]磺酰基]氨基] -N-羥基-2-甲基丙酰胺
生產(chǎn)廠家
210755-45-6, 2-[[[4-(4-氟苯氧基)苯基]磺酰基]氨基] -N-羥基-2-甲基丙酰胺 相關(guān)搜索:
- Heterocycles
- Sulfur & Selenium Compounds
- Pharmaceuticals
- Pfizer Compounds
- Intermediates & Fine Chemicals
- Inhibitors
- Aromatics
- Amines
- 抑制劑
- C16H16FN2O5S
- 化合物 CP-471474
- 化合物 T22685
- 2-[[[4-(4-氟苯氧基)苯基]磺?；鵠氨基] -N-羥基-2-甲基丙酰胺
- 210755-45-6
- Propanamide, 2-[[[4-(4-fluorophenoxy)phenyl]sulfonyl]amino]-N-hydroxy-2-methyl-
- 2-(4-(4-Fluorophenoxy)phenylsulfonamido)-N-hydroxy-2-methylpropanamide
- 2-[[[4-(4-Fluorophenoxy)phenyl]sulfonyl]amino]-N-hydroxy-2-methylpropanamide
- CP 471,474
- PF-1626077